The osteoarthritis management sector represents the largest application area for acemetacin, leveraging its potent anti-inflammatory and analgesic properties for degenerative joint disease affecting millions worldwide. In knee osteoarthritis, acemetacin provides effective symptomatic relief for pain, stiffness, and functional limitation, supporting mobility and quality of life in aging populations. The drug's ability to reduce synovial inflammation and inhibit prostaglandin synthesis addresses the inflammatory component of osteoarthritis pathophysiology beyond simple analgesia.

In hip and spine osteoarthritis, acemetacin supports conservative management strategies delaying or avoiding surgical intervention. The sustained-release formulation enables convenient twice-daily dosing that maintains therapeutic coverage throughout waking hours. Combination with non-pharmacological interventions including physical therapy, weight management, and exercise programs represents standard-of-care multidisciplinary approaches. The acute flare management segment utilizes higher initial doses with subsequent tapering to control episodic symptom exacerbations.

The perioperative orthopedic surgery application includes pre-emptive analgesia and postoperative pain management following joint replacement and arthroscopic procedures. Acemetacin's opioid-sparing potential reduces postoperative nausea, sedation, and constipation while supporting earlier mobilization. Regulatory agencies have approved acemetacin for osteoarthritis across multiple jurisdictions with established dosing guidelines. The integration of acemetacin into osteoarthritis treatment algorithms, clinical practice guidelines, and step-care protocols underscores its role as a foundational NSAID therapy. Training programs for primary care physicians, rheumatologists, and orthopedic surgeons emphasize risk stratification, appropriate patient selection, and gastrointestinal protection strategies.

How is acemetacin used in knee osteoarthritis management? Acemetacin provides effective anti-inflammatory and analgesic relief for pain, stiffness, and functional limitation, supporting mobility and quality of life.

What advantages does sustained-release acemetacin offer? Sustained-release formulations enable convenient twice-daily dosing with consistent plasma concentrations, improving adherence and reducing peak-related adverse effects.

Can acemetacin support perioperative orthopedic pain management? Yes, acemetacin provides effective opioid-sparing analgesia for pre-emptive and postoperative pain management following joint replacement and arthroscopic procedures.